A new research has shown that liver cancer, a growing health challenge often diagnosed in its advanced stages, can be prevented by changing the metabolic programming of cells as a target therapy.

The research, conducted over six years, is a collaborative effort of scientists from CSIR-Central Drug Research Institute (CSIR-CDRI), Central Institute of Medicinal and Aromatic Plants (CIMAP), and Centre of Biomedical Research (CBMR), SGPGIMS, Lucknow.